Enterobacter sakazakii: an emerging pathogen in powdered infant formula
- PMID: 16511766
- DOI: 10.1086/501019
Enterobacter sakazakii: an emerging pathogen in powdered infant formula
Abstract
Enterobacter sakazakii represents a significant risk to the health of neonates. This bacterium is an emerging opportunistic pathogen that is associated with rare but life-threatening cases of meningitis, necrotizing enterocolitis, and sepsis in premature and full-term infants. Infants aged <28 days are considered to be most at risk. Feeding with powdered infant formula (PIF) has been epidemiologically implicated in several clinical cases. Infants should be exclusively breast-fed for the first 6 months of life, and those who are not should be provided with a suitable breast-milk substitute. PIF is not a sterile product; to reduce the risk of infection, the reconstitution of powdered formula should be undertaken by caregivers using good hygienic measures and in accordance with the product manufacturer's food safety guidelines.
Similar articles
-
Enterobacter sakazakii an emerging bacterial pathogen with implications for infant health.Minerva Pediatr. 2007 Apr;59(2):137-48. Minerva Pediatr. 2007. PMID: 17404564 Review.
-
Enterobacter sakazakii: a coliform of increased concern to infant health.Int J Food Microbiol. 2005 Sep 25;104(1):1-34. doi: 10.1016/j.ijfoodmicro.2005.02.013. Int J Food Microbiol. 2005. PMID: 16039742 Review.
-
[Enterobacter sakazakii in powdered infant food formulas].Can J Microbiol. 2009 May;55(5):473-500. doi: 10.1139/w08-131. Can J Microbiol. 2009. PMID: 19483777 Review. French.
-
Cronobacter ('Enterobacter sakazakii'): current status and future prospects.Lett Appl Microbiol. 2009 Aug;49(2):153-9. doi: 10.1111/j.1472-765X.2009.02651.x. Epub 2009 May 27. Lett Appl Microbiol. 2009. PMID: 19486285 Review.
-
[Enterobacter sakazakii: an emerging pathogen!].Pediatr Med Chir. 2005 Jan-Apr;27(1-2):98-100. Pediatr Med Chir. 2005. PMID: 16922052 Italian.
Cited by
-
Comparison of the phenotyping methods ID 32E and VITEK 2 compact GN with 16S rRNA gene sequencing for the identification of Enterobacter sakazakii.J Clin Microbiol. 2007 Jun;45(6):2048-50. doi: 10.1128/JCM.00961-06. Epub 2007 Apr 11. J Clin Microbiol. 2007. PMID: 17428936 Free PMC article.
-
Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires the host cell cytoskeleton and is enhanced by disruption of tight junction.Infect Immun. 2008 Feb;76(2):562-70. doi: 10.1128/IAI.00937-07. Epub 2007 Dec 10. Infect Immun. 2008. PMID: 18070906 Free PMC article.
-
Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care.Antibiotics (Basel). 2018 Feb 27;7(1):17. doi: 10.3390/antibiotics7010017. Antibiotics (Basel). 2018. PMID: 29495476 Free PMC article. Review.
-
Large-Scale Production of Cronobacter sakazakii Bacteriophage Φ CS01 in Bioreactors via a Two-Stage Self-Cycling Process.J Microbiol Biotechnol. 2021 Oct 28;31(10):1430-1437. doi: 10.4014/jmb.2107.07017. J Microbiol Biotechnol. 2021. PMID: 34489375 Free PMC article.
-
Enterobacter sakazakii targets DC-SIGN to induce immunosuppressive responses in dendritic cells by modulating MAPKs.J Immunol. 2009 Nov 15;183(10):6588-99. doi: 10.4049/jimmunol.0902029. Epub 2009 Oct 21. J Immunol. 2009. PMID: 19846880 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical